Concepedia

Linus Amarikwa

LA

Statistics

Publications

8

Citations

277

H-Index

8

Active since

2017

Affiliations

Stanford University(Current)

Boehringer Ingelheim (United States)

Amgen (United States)

Boehringer Ingelheim (Egypt)

Cedars-Sinai Medical Center

Linus Amarikwa is an author at Stanford University specializing in medicine, thyroid eye disease, and ophthalmology.

ORCID

Publications per year

2017–2023

8

Publications

8

Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease

Connie M. Sears, Amee D. Azad, Linus Amarikwa et al. · American Journal of Ophthalmology · 2022 · 82 citations · Full text

, , +12

Teprotumumab-Related Hyperglycemia

Linus Amarikwa, Abubakr Mohamed, Sun H. Kim et al. · The Journal of Clinical Endocrinology & Metabolism · 2022 · 40 citations · Full text

, , +16

Design of a novel continuous flow reactor for low pH viral inactivation

Stephanie A. Parker, Linus Amarikwa, Kevin Vehar et al. · Biotechnology and Bioengineering · 2017 · 37 citations

, , +14

Teprotumumab-Related Adverse Events in Thyroid Eye Disease

Shreya Shah, Linus Amarikwa, Connie M. Sears et al. · Ophthalmology · 2023 · 36 citations · Full text

, , +14

Design, construction, and optimization of a novel, modular, and scalable incubation chamber for continuous viral inactivation

Raquel Orozco, Scott Godfrey, Jon Coffman et al. · Biotechnology Progress · 2017 · 33 citations

, , +15

1–5 of 8